Central Pacific Bank Trust Division Has $3.39 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Central Pacific Bank Trust Division lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,491 shares of the medical equipment provider’s stock after selling 172 shares during the quarter. Central Pacific Bank Trust Division’s holdings in Intuitive Surgical were worth $3,388,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. GAMMA Investing LLC boosted its holdings in Intuitive Surgical by 10.0% during the 4th quarter. GAMMA Investing LLC now owns 5,597 shares of the medical equipment provider’s stock worth $2,921,000 after acquiring an additional 507 shares during the last quarter. Versant Capital Management Inc boosted its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Versant Capital Management Inc now owns 688 shares of the medical equipment provider’s stock worth $359,000 after acquiring an additional 148 shares during the period. SMART Wealth LLC purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $290,000. Exome Asset Management LLC lifted its stake in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, Brass Tax Wealth Management Inc. increased its stake in Intuitive Surgical by 2.2% in the 3rd quarter. Brass Tax Wealth Management Inc. now owns 2,558 shares of the medical equipment provider’s stock worth $1,257,000 after acquiring an additional 56 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This trade represents a 88.63 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 2.1 %

Shares of Intuitive Surgical stock traded up $11.25 during trading on Friday, hitting $535.28. 504,698 shares of the stock traded hands, compared to its average volume of 701,740. Intuitive Surgical, Inc. has a 52-week low of $320.26 and a 52-week high of $556.23. The stock’s fifty day simple moving average is $532.28 and its 200 day simple moving average is $489.92. The firm has a market cap of $190.66 billion, a P/E ratio of 86.06, a price-to-earnings-growth ratio of 5.31 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ISRG. Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Leerink Partners boosted their price objective on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Raymond James raised their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.